Cancer Clinical Trial
— PSPOfficial title:
Partnership-Project - Reinforcing Partnership Between Cancer Patient, General Practitioner and Oncologist During Chemotherapy - a Randomized Controlled Trial
| Verified date | October 2020 |
| Source | University of Southern Denmark |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Background International guidelines underline the importance of strengthening the coordination and continuity of cancer care. The different roles of general practitioners and oncologists with regard to treatment, follow-up and rehabilitation during and after cancer treatment are often obscure to cancer patients. Parallel courses of healthcare are often taking place instead of coordinated care characterized by continuity and partnership between care providers. Patients may feel uncertain about the health professionals' skills and area of responsibility. Healthcare seeking and support during and after cancer treatment may, therefore, be inappropriate, leaving patients feeling insecure and lost between care providers.The study aims to design and evaluate a new way of communication and shared decision-making that brings the patient, the oncologist and general practitioner together in a shared video-consultation in the early phase of chemotherapeutic treatment. The effect of the intervention in addition to usual care will be tested in a randomized controlled trial at Vejle Hospital in the Region of Southern Denmark. Based on sample size calculation, investigators intent to include 300 patients at the Department of Oncology and their general practitioners. Results and process outcomes will be evaluated qualitatively and quantitatively, questionnaires to patients, general practitioners and oncologists, and data from registers.
| Status | Completed |
| Enrollment | 281 |
| Est. completion date | August 2020 |
| Est. primary completion date | August 2020 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Newly referred cancer patient scheduled for chemotherapy at the Department for Oncology, Vejle Hospital, Region of Southern Denmark - Aged 18 years and over - Able to speak and read Danish - Mentally able to cooperate - Listed with a general practitioner (98 % of the danish population) - Written and verbal informed consent given Exclusion Criteria: - none |
| Country | Name | City | State |
|---|---|---|---|
| Denmark | Department of Oncology, Vejle Hospital, Region of Southern Denmark | Vejle |
| Lead Sponsor | Collaborator |
|---|---|
| University of Southern Denmark | National Research Center of Cancer Rehabilitation, Odense Patient Data Explorative Network, Region of Southern Denmark, Research Unit of General Practice, Odense, Vejle Hospital |
Denmark,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Shared Care questionnaire | Patient reported outcome measure. Cancer patients assessment of their cancer trajectory and their assessment of the cooperation between their General Practitioner and the oncologist specialist. | 7 month after inclusion | |
| Secondary | Illness Intrusiveness Rating Scale (IIRS) | Patient reported outcome measure. Patients assessment of the cancer disease influence on their daily living. | 4 and 7 month after inclusion | |
| Secondary | European Organisation for Research and Treatment of Cancer - Quality of Life questionnaire - Core 30 (EORTC QLQ C30) | Patient reported outcome measure. Cancer patients assessment of their quality of life | 4 and 7 month after inclusion | |
| Secondary | European Organisation for Research and Treatment of Cancer - Quality of Life- information questionnaire (EORTC QLQ INFO25) | 4 and 7 month after inclusion | ||
| Secondary | Generalised Anxiety Disorder Assessment (GAD-7) | Patient reported outcome measure. Screening tool and severity measure for generalised anxiety disorder | 4 and 7 month after inclusion | |
| Secondary | Patient Health Questionnaire (PHQ-9) | Patient reported outcome measure.The questionnaire monitor the severity of depression and response to treatment. | 4 and 7 month after inclusion | |
| Secondary | Oncologist assessment of a video consultation between the patient, General practitioner and oncologist. | It measures the oncologist perception of the benefits with the video consultation intervention. Only the intervention group | Directly after the video consultation intervention | |
| Secondary | General practitioners assessment of a video consultation between the patient, General practitioner and oncologist. | It measures the General Practitioners perception of the benefits with the video consultation intervention. Only the intervention group. | Directly after the video consultation intervention | |
| Secondary | Patients assessment of a video consultation between the patient, General practitioner and oncologist. | It measures the patients perception of the benefits with the video consultation intervention.Only the intervention group | Directly after the video consultation intervention | |
| Secondary | General Practitioner cancer trajectory assessment | The General Practitioners assessment of the cooperation between the primary and secondary care regarding af specific cancer patient. | 4 month after the inclusion of the patient. |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|